通过纠正甲状腺功能低下症来对脏损伤产生cordycepin的影响
Hongyan Li1, Lili Qiao1, Jinhui Ma1
1Department of Endocrinology, Affiliated Hospital of Hebei University, Baoding City, Hebei Province, China.
Pakistan journal of pharmaceutical sciences
|November 4, 2024
概括
在甲状腺功能低下的小鼠中,康迪塞平治疗改善了甲状腺功能,并减轻了损伤. 这种天然化合物降低了血脂水平和足细胞损伤标志物,对脏健康产生保护作用.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲状腺功能低下症与损伤和脂质代谢障碍有关.
- 甲状腺甲酸 (PTU) 用于为研究建立甲状腺功能低下的老鼠模型.
- 足细胞损伤是病理的一个关键指标.
研究的目的:
- 在甲状腺功能低下症的小鼠模型中研究cordycepin的保护作用.
- 探索甲状腺功能恢复对低甲状腺症引起的损伤的影响.
- 评估康迪塞宾对甲状腺功能,功能和脂质概况的影响.
主要方法:
- 使用甲 (PTU) 建立甲状腺功能低下的老鼠模型.
- 用康迪塞宾来评估其治疗效果.
- 评估一般状态,甲状腺功能,功能和血液脂质.
- 组织病理学检查脏组织.
- 免疫组织化学检测MCP-1和Desmin蛋白表达.
主要成果:
- 甲状腺功能低下症在老鼠中诱导损伤和脂质失调,其证据是血脂和MCP-1表达的增加.
- 科迪塞宾的使用改善了甲状腺功能,并显著改善了损伤.
- 康迪塞平治疗降低了血脂水平,并降低了脏组织中MCP-1和Desmin蛋白的表达.
结论:
- 科尔迪塞宾通过改善甲状腺功能,在甲状腺功能低下症中显示出显著的保护作用.
- 该化合物减轻脏损伤和与甲状腺功能低下相关的脂质代谢障碍.
- 科迪塞宾有潜力延缓在甲状腺功能低下症下脏损伤的进展.
相关概念视频
01:11Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
01:22Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
142
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
142
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
463
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
463
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
01:16Antihypertensive Drugs: Action of Diuretics
623
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
623